DYNAMICS OF GLYCEMIC CONTROL AFTER RENAL DENERVATION IN PATIENTS WITH RESISTANT HYPERTENSION AND TYPE 2 DIABETES MELLITUS

Por A. Yu. Falkovskaya, V. F. Mordovin, S. Ye. Pekarsky, A. Ye. Bayev, G. V. Semke, T. M. Ripp, Ye. S. Kravtchenko, I. V. Zyubanova
Publicado em 2015-10-01

Positive effects of renal denervation on markers of cardiovascular inflammation and left ventricular mass. 24-months follow-up

Por E. S. Sitkova, V. F. Mordovin, S. E. Pekarskiy, T. M. Ripp, T. R. Ryabova, А. Yu. Falkovskaya, V. A. Lichikaki, I. V. Zyubanova, A. Е. Baev, A. M. Gusakova
Publicado em 2021-03-01

Long-term outcomes of renal denervation and related sex characteristics: data from a three-year follow-up

Por I. V. Zyubanova, V. F. Mordovin, A. Yu. Falkovskaya, S. E. Pekarsky, T. M. Ripp, M. A. Manukyan, V. A. Lichikaki, A. M. Gusakova, T. R. Ryabova, A. E. Baev
Publicado em 2021-05-01

Distal renal denervation: cardioprotection in patients with resistant hypertension

Por E. S. Sitkova, V. F. Mordovin, S. E. Pekarsky, T. M. Ripp, A. Yu. Falkovskaya, V. A. Lichikaki, I. V. Zyubanova, A. E. Baev, T. R. Ryabova, O. V. Mochula, V. Yu. Usov
Publicado em 2020-09-01